Cytek Biosciences, Inc. (CTKB)

NASDAQ: CTKB · Real-Time Price · USD

4.610

-0.310 (-6.30%)

At close: May 8, 2026, 4:00 PM EDT

4.650

+0.040 (0.87%)

After-hours: May 8, 2026, 5:05 PM EDT

Cytek Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	65.67	90.85	98.72	167.3	296.6	364.62
Short-Term Investments	196.56	170.68	179.15	95.11	44.55	-
Cash & Short-Term Investments	262.23	261.53	277.86	262.41	341.15	364.62
Cash Growth	-1.28%	-5.88%	5.89%	-23.08%	-6.44%	120.67%
Accounts Receivable	51.9	62.51	60.59	55.93	48.86	29.76
Inventory	-	-	-	60.88	48.15	32.17
Other Current Assets	15.38	19.53	14.1	12.85	15.85	5.18
Total Current Assets	379.3	392	396.45	392.06	454.02	431.73
Net Property, Plant & Equipment	31.11	29.32	28.13	29.26	27.57	5.85
Other Intangible Assets	15.7	16.82	20.13	23.08	4.33	4.74
Goodwill	16.69	16.7	16.66	16.18	10.14	10.14
Other Long-Term Assets	6.31	6.7	38.13	33.87	23.42	10.84
Total Assets	449.11	461.54	499.5	494.46	519.48	463.31
Accounts Payable	6.74	6.41	5.53	3.03	4.81	3.03
Accrued Expenses	19.78	23.42	21.44	20.04	21.13	15.25
Unearned Revenue	30.03	28.5	25.49	22.7	12.99	7.08
Other Current Liabilities	24.38	19.47	15.2	10.46	10.12	7.82
Total Current Liabilities	80.94	77.8	67.66	56.23	49.04	33.18
Long-Term Debt	0.39	0.53	1.05	1.65	2.27	-
Long-Term Leases	13.44	14.04	7.55	9.48	12.31	-
Other Long-Term Liabilities	26.71	27.43	27.5	34.04	30.31	24.74
Total Long-Term Liabilities	40.53	42	36.1	45.17	44.89	24.74
Total Liabilities	121.47	119.8	103.76	101.39	93.93	57.92
Common Stock	0.13	0.13	0.13	0.13	0.14	0.13
Additional Paid-in Capital	445.75	441.11	430.79	423.39	442.89	423.63
Accumulated Other Comprehensive Income	2.37	2.24	0.02	-1.28	-0.7	0.9
Retained Earnings	-120.6	-101.74	-35.2	-29.18	-17.03	-19.61
Total Common Shareholders' Equity	327.64	341.74	395.74	393.06	425.3	405.04
Minority Interest	-	-	-	-	0.25	0.34
Shareholders' Equity	327.64	341.74	395.74	393.06	425.55	405.39
Total Liabilities & Equity	449.11	461.54	499.5	494.46	519.48	463.31
Total Debt	13.83	14.57	8.6	11.13	14.58	0
Net Cash (Debt)	248.4	246.96	269.26	251.28	326.57	364.62
Net Cash Growth	0.58%	-8.28%	7.15%	-23.05%	-10.44%	120.67%
Net Cash Per Share	1.94	1.93	2.06	1.86	2.36	4.47
Book Value	327.64	341.74	395.74	393.06	425.3	405.04
Book Value Per Share	2.56	2.68	3.03	2.91	3.07	4.97
Tangible Book Value	295.25	308.22	358.95	353.8	410.82	390.16
Tangible Book Value Per Share	2.31	2.41	2.75	2.62	2.96	4.78

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q